clinical trials

You have access
State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA

Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
You have access
A Review of the Evidence Supporting the Vitamin D-Cancer Prevention Hypothesis in 2017
WILLIAM B. GRANT

Anticancer Research February 2018, 38 (2) 1121-1136;
You have access
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA

Anticancer Research January 2017, 37 (1) 21-33;
You have access
Targeted Therapy for NSCLC–A Double-edged Sword?
WOLFRAM C. M. DEMPKE

Anticancer Research May 2015, 35 (5) 2503-2512;
You have access
Mechanisms and Clinical Significance of Histone Deacetylase Inhibitors: Epigenetic Glioblastoma Therapy
PHILIP LEE, BEN MURPHY, RICKEY MILLER, VIVEK MENON, NAREN L. BANIK, PIERRE GIGLIO, SCOTT M. LINDHORST, ABHAY K. VARMA, WILLIAM A. VANDERGRIFT, SUNIL J. PATEL and ARABINDA DAS

Anticancer Research February 2015, 35 (2) 615-625;
You have access
Current Status in Chemotherapy for Advanced Pancreatic Adenocarcinoma
HUYNH CAO, DUONG LE and LI-XI YANG

Anticancer Research May 2013, 33 (5) 1785-1791;

Main menu